{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:56:01Z","timestamp":1790020561163,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Microbiology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.mib.2016.04.006","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T22:02:35Z","timestamp":1464904955000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Malaria vaccines and human immune responses"],"prefix":"10.1016","volume":"32","author":[{"given":"Carole A","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidel","family":"Zavala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mib.2016.04.006_bib0250","unstructured":"Organization WH: World Malaria Report 2014. http:\/\/wwwwhoint\/malaria\/publications\/world_malaria_report_2014\/en\/2014."},{"key":"10.1016\/j.mib.2016.04.006_bib0255","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1016\/j.vaccine.2015.09.060","article-title":"Development of vaccines for Plasmodium vivax malaria","volume":"33","author":"Mueller","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2016.04.006_bib0260","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/216160a0","article-title":"Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei","volume":"216","author":"Nussenzweig","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.mib.2016.04.006_bib0265","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4269\/ajtmh.1975.24.397","article-title":"Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites","volume":"24","author":"Clyde","year":"1975","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.mib.2016.04.006_bib0270","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/339409","article-title":"Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites","volume":"185","author":"Hoffman","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2016.04.006_sbref0275","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS, S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"Rts,S CTP","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.mib.2016.04.006_bib0280","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/600120","article-title":"Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S\/AS01B and RTS,S\/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection","volume":"200","author":"Kester","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2016.04.006_bib0285","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12936-015-0605-7","article-title":"The effect of immunization schedule with the malaria vaccine candidate RTS, S\/AS01E on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants","volume":"14","author":"Ajua","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.mib.2016.04.006_bib0290","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199701093360202","article-title":"A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group","volume":"336","author":"Stoute","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2016.04.006_bib0295","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00281-015-0479-3","article-title":"From the draining lymph node to the liver: the induction and effector mechanisms of malaria-specific CD8+ T cells","volume":"37","author":"Radtke","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.mib.2016.04.006_sbref0300","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic diversity and protective efficacy of the RTS, S\/AS01 malaria vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2016.04.006_sbref0305","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.1241800","article-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","volume":"341","author":"Seder","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.mib.2016.04.006_bib0310","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMoa0805832","article-title":"Protection against a malaria challenge by sporozoite inoculation","volume":"361","author":"Roestenberg","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2016.04.006_sbref0315","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1073\/pnas.1220360110","article-title":"Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity","volume":"110","author":"Bijker","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mib.2016.04.006_bib0320","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1017\/S0031182015000761","article-title":"Immune activation and induction of memory: lessons learned from controlled human malaria infection with Plasmodium falciparum","volume":"143","author":"Scholzen","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.mib.2016.04.006_bib0325","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-3024.2006.00808.x","article-title":"Immune effector mechanisms in malaria","volume":"28","author":"Marsh","year":"2006","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.mib.2016.04.006_bib0330","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/192733a0","article-title":"Gamma-globulin and acquired immunity to human malaria","volume":"192","author":"Cohen","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.mib.2016.04.006_bib0335","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4269\/ajtmh.1991.45.297","article-title":"Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria","volume":"45","author":"Sabchareon","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.mib.2016.04.006_bib0340","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1073\/pnas.1001323107","article-title":"A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray","volume":"107","author":"Crompton","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mib.2016.04.006_bib0345","first-page":"1","article-title":"Progress and prospects for blood-stage malaria vaccines","author":"Miura","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.mib.2016.04.006_bib0350","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuw001","article-title":"Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria","author":"Beeson","year":"2016","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.mib.2016.04.006_bib0355","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1008115","article-title":"A field trial to assess a blood-stage malaria vaccine","volume":"365","author":"Thera","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2016.04.006_bib0360","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature10606","article-title":"Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum","volume":"480","author":"Crosnier","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.mib.2016.04.006_sbref0365","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.chom.2014.11.017","article-title":"A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys","volume":"17","author":"Douglas","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mib.2016.04.006_bib0370","doi-asserted-by":"crossref","first-page":"e1003943","DOI":"10.1371\/journal.ppat.1003943","article-title":"Plasmodium falciparum erythrocyte invasion: combining function with immune evasion","volume":"10","author":"Wright","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2016.04.006_bib0375","doi-asserted-by":"crossref","first-page":"14081","DOI":"10.1038\/srep14081","article-title":"Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malaria","volume":"5","author":"Llewellyn","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.mib.2016.04.006_bib0380","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.immuni.2015.02.012","article-title":"Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria","volume":"42","author":"Boyle","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.mib.2016.04.006_bib0385","doi-asserted-by":"crossref","first-page":"e20947","DOI":"10.1371\/journal.pone.0020947","article-title":"Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay","volume":"6","author":"Miura","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mib.2016.04.006_sbref0390","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw039","article-title":"Demonstration of the blood-stage controlled human malaria infection model to assess efficacy of the Plasmodium falciparum AMA1 Vaccine FMP2.1\/AS01","author":"Payne","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2016.04.006_bib0395","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nm0398-358","article-title":"Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria","volume":"4","author":"Bull","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.mib.2016.04.006_bib0400","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.mib.2012.03.003","article-title":"Antigenic variation and the generation of diversity in malaria parasites","volume":"15","author":"Kirkman","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.mib.2016.04.006_bib0405","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/bs.apar.2015.02.004","article-title":"PfEMP1 - a parasite protein family of key importance in Plasmodium falciparum malaria immunity and pathogenesis","volume":"88","author":"Hviid","year":"2015","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.mib.2016.04.006_bib0410","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1007\/s00018-014-1614-3","article-title":"Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates","volume":"71","author":"Chan","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.mib.2016.04.006_bib0415","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pt.2013.12.007","article-title":"Malaria, primigravidae, and antibodies: knowledge gained and future perspectives","volume":"30","author":"Ataide","year":"2014","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.mib.2016.04.006_bib0420","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1517\/14712598.2015.1049595","article-title":"Developing vaccines to prevent malaria in pregnant women","volume":"15","author":"Tuikue-Ndam","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.mib.2016.04.006_sbref0425","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature16450","article-title":"A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigens","volume":"529","author":"Tan","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.mib.2016.04.006_bib0430","doi-asserted-by":"crossref","first-page":"e1004871","DOI":"10.1371\/journal.ppat.1004871","article-title":"Targeting human transmission biology for malaria elimination","volume":"11","author":"Nilsson","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2016.04.006_bib0435","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0014-4894(58)90036-5","article-title":"Changes in infectiousness of malarial gametocytes. II. Analysis of the possible causative factors","volume":"7","author":"Huff","year":"1958","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.mib.2016.04.006_bib0440","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.959832","article-title":"Successful immunization against the sexual stages of Plasmodium gallinaceum","volume":"193","author":"Gwadz","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.mib.2016.04.006_bib0445","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/263057a0","article-title":"Malaria transmission blocked by immunisation with gametes of the malaria parasite","volume":"263","author":"Carter","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.mib.2016.04.006_bib0450","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1084\/jem.158.3.976","article-title":"Target antigens of transmission-blocking immunity on gametes of Plasmodium falciparum","volume":"158","author":"Rener","year":"1983","journal-title":"J Exp Med"},{"key":"10.1016\/j.mib.2016.04.006_bib0455","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1586\/14760584.2015.993383","article-title":"Toward the development of effective transmission-blocking vaccines for malaria","volume":"14","author":"Nikolaeva","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.mib.2016.04.006_bib0460","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/bs.apar.2015.04.001","article-title":"Development of malaria transmission-blocking vaccines: from concept to product","volume":"89","author":"Wu","year":"2015","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.mib.2016.04.006_bib0465","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1038\/srep03418","article-title":"The relevance and applicability of oocyst prevalence as a read-out for mosquito feeding assays","volume":"3","author":"Stone","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.mib.2016.04.006_sbref0470","doi-asserted-by":"crossref","first-page":"e57909","DOI":"10.1371\/journal.pone.0057909","article-title":"Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assays","volume":"8","author":"Miura","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mib.2016.04.006_bib0475","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ijpara.2012.09.002","article-title":"Measuring the blockade of malaria transmission \u2014 an analysis of the Standard Membrane Feeding Assay","volume":"42","author":"Churcher","year":"2012","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.mib.2016.04.006_bib0480","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1016\/j.vaccine.2014.07.030","article-title":"Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward","volume":"32","author":"Nunes","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2016.04.006_sbref0485","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.1520426112","article-title":"Plasmodium evasion of mosquito immunity and global malaria transmission: The lock-and-key theory","volume":"112","author":"Molina-Cruz","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mib.2016.04.006_sbref0490","doi-asserted-by":"crossref","first-page":"E6736","DOI":"10.1073\/pnas.1521077112","article-title":"Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi","volume":"112","author":"Gantz","year":"2015","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Current Opinion in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527416300418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527416300418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T08:50:54Z","timestamp":1536655854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369527416300418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":49,"alternative-id":["S1369527416300418"],"URL":"https:\/\/doi.org\/10.1016\/j.mib.2016.04.006","relation":{},"ISSN":["1369-5274"],"issn-type":[{"value":"1369-5274","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malaria vaccines and human immune responses","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mib.2016.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}